Abstract 12863: Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis of Mortality and Major Thromboembolic Events in 16,496 Patients From the MAGELLAN and MARINER Trials

IntroductionThromboprophylaxis extended after hospital discharge in high- risk medical patients remains controversial due to uncertainty about the benefit for preventing fatal or major thromboembolic events, and the risk of major bleeding offsetting reduced non-fatal venous thromboembolism.Hypothesi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A12863-A12863
Hauptverfasser:	Raskob, Gary E, Spyropoulos, Alex, Cohen, Alexander T, Spiro, Theodore, Lu, Wentao, Levitan, Bennett, Suh, Eun Young, Barnathan, Elliot S
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!